Tang Dong-ling, Zhou Xin, Zhou Ke-yuan, Li Xia, Zhao Lei, Liu Fang, Zheng Fang, Liu Song-mei
Department of Clinical Laboratory, Zhongnan Hospital, Wuhan University, Wuhan, Hubei, P. R. China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Dec;22(6):636-40.
To explore the prevalence of mitochondrial DNA (mtDNA) mutations in patients with type 2 diabetes mellitus in Hubei.
A total of 184 cases of type 2 diabetes mellitus and 210 matched healthy controls with normal glucose tolerance were recruited for the study. The variants of mtDNA, including MIND13316 (G-->A), MIND13394 (T-->C), MTTE14693 (A-->G), MTTL1 3243 (A-->G), MTRNA1310 (C-->T) and 16189 (T-->C), were screened using PCR-restriction fragment length polymorphism (PCR-RFLP) analysis and DNA sequencing. The mutations were analyzed by mfold or tRNAscan-SE softwares.
The mutation rates of 3316 (G-->A), 3394 (T-->C), 14693 (A-->G) were 3.26%, 2.72% and 2.17% respectively in type 2 diabetes group, whereas in the control group, the point mutations of 3394 (T-->C) and 14693 (A-->G) were not detected, but two subjects with 3316 (G-->A) were found (0.99%). There were significant differences in mutation rates of 3394 (T-->C) and 14693 (A-->G) between the two groups (P<0.05). In 4 of 184 cases, a T to C transition at nucleotide position 14693 was uncovered for the first time. The prevalence of 16189 variant among type 2 diabetes was significantly higher that of the controls (36.9% vs 26.6%, P=0.03). Moreover, the type 2 diabetes with 16189 variant showed higher fasting serum insulin level and higher HOMA-IR level than those without 16189 variant; stepwise multiple regression analysis showed the 16189 variant was an independent factor contributing to HOMA-IR (R(2)=0.043, P=0.037). Secondary structure prediction revealed that there were differences in 3394 T-->C vs wild-type ND1 protein and in 14693 A-->G vs wild-type tRNA(Glu) protein.
The mutations of 3394 (T-->C) and 14693 (A-->G) may contribute to the genetic predisposition to type 2 diabetes; 16189 (T-->C) variant is associated with insulin resistance and risk factor of diabetes.
探讨湖北地区2型糖尿病患者线粒体DNA(mtDNA)突变的发生率。
本研究共纳入184例2型糖尿病患者和210例糖耐量正常的匹配健康对照。采用聚合酶链反应-限制性片段长度多态性分析(PCR-RFLP)和DNA测序技术筛查mtDNA的变异,包括MIND13316(G→A)、MIND13394(T→C)、MTTE14693(A→G)、MTTL1 3243(A→G)、MTRNA1310(C→T)和16189(T→C)。通过mfold或tRNAscan-SE软件分析突变情况。
2型糖尿病组中3316(G→A)、3394(T→C)、14693(A→G)的突变率分别为3.26%、2.72%和2.17%;而对照组未检测到3394(T→C)和14693(A→G)的点突变,但发现2例携带3316(G→A)(0.99%)。两组间3394(T→C)和14693(A→G)的突变率存在显著差异(P<0.05)。在184例患者中的4例中,首次发现核苷酸位置14693处发生了T到C的转换。2型糖尿病患者中16189变异的发生率显著高于对照组(36.9%对26.6%,P=0.03)。此外,携带16189变异的2型糖尿病患者空腹血清胰岛素水平和稳态模型评估胰岛素抵抗(HOMA-IR)水平高于未携带16189变异的患者;逐步多元回归分析显示16189变异是导致HOMA-IR的独立因素(R²=0.043,P=0.037)。二级结构预测显示,3394 T→C与野生型ND1蛋白以及14693 A→G与野生型tRNA(Glu)蛋白存在差异。
3394(T→C)和14693(A→G)突变可能是2型糖尿病遗传易感性的原因;16189(T→C)变异与胰岛素抵抗及糖尿病危险因素相关。